|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income attributable to Sotheby's | |||||
| Adjustments to reconcile net income attributable to Sotheby's to net cash (used) provided by operating activities: | |||||
| Extinguishment of debt | |||||
| Write-off of credit facility fees | |||||
| Depreciation and amortization | |||||
| Gain from recognition of cumulative translation adjustment upon liquidation of foreign subsidiary | |||||
| Deferred income tax benefit | |||||
| Share-based payments | |||||
| Net pension benefit | |||||
| Inventory writedowns and bad debt provisions | |||||
| Amortization of debt issuance costs | |||||
| Excess tax benefits from share-based payments | |||||
| Equity in earnings of investees | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Client payables | |||||
| Related party client payables (see Note 27) | |||||
| Inventory (see Note 13) | |||||
| Prepaid expenses and other current assets | |||||
| Other long-term assets | |||||
| Income tax receivables and deferred income tax assets | |||||
| Accrued income taxes and deferred income tax liabilities | |||||
| Accounts payable and accrued liabilities and other liabilities | |||||
| Restricted cash related to interest on 2022 Senior Notes (see Note 9) | |||||
| Changes in other operating assets and liabilities (see Note 15) | |||||
| Net cash (used) provided by operating activities | |||||
| Investing Activities: | |||||
| Funding of notes receivable | |||||
| Collections of notes receivable | |||||
| Capital expenditures | |||||
| Acquisitions, net of cash acquired (see Notes 8 and 9) | |||||
| Funding of investments | |||||
| Distributions from investees | |||||
| Proceeds from the sale of equity investment | |||||
| Proceeds from company-owned life insurance | |||||
| Settlement of net investment hedges (see Note 12) | |||||
| (Increase) decrease in restricted cash | |||||
| Net cash (used) provided by investing activities | |||||
| Financing Activities: | |||||
| Proceeds from credit facility borrowings | |||||
| Repayments of credit facility borrowings | |||||
| Proceeds from refinancing of York Property Mortgage | |||||
| Repayments of York Property Mortgage | |||||
| Restricted cash related to York Property Mortgage (see Note 9) | |||||
| Proceeds from the issuance of 2025 Senior Notes (see Note 11) | |||||
| Restricted cash related to 2022 Senior Notes, principal and premium (see Note 9) | |||||
| Settlement of 2022 Senior Notes, including call premium (see Note 11) | |||||
| Debt issuance and other borrowing costs | |||||
| Repurchases of common stock | |||||
| Dividends paid | |||||
| Proceeds from exercise of employee stock options | |||||
| Excess tax benefits from share-based payments | |||||
| Funding of employee tax obligations upon the vesting of share-based payments | |||||
| Net cash used by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| (Decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...